Abstract:Background: Early studies have highlighted the possible development of dysgeusia and anosmia in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, and these manifestations should be considered a potential indication of coronavirus disease 19 (COVID-19). As potential contributors to these symptoms, dentists should perform careful oral and oropharyngeal examinations and document suspicious oral lesions in patients with COVID-19, especially in those who complain of loss of taste and smell. The study's objective was to assess the prevalence of oral manifestations among ambulatory unvaccinated symptomatic patients with suspected COVID-19 during the acute phase of the disease. Methods: This cross-sectional study evaluated oral manifestations in adults (aged ≥ 18 years) with suspected and confirmed SARS-CoV-2 infection. Chi-square and Fisher's exact tests were used to compare data between the groups (rRT-PCR-positive and rRT-PCR-negative patients). Results: One hundred thirty-six participants were included. Most were female (n = 79; 58.1%), with a mean age of 39.53 (± 14.17) years. Of these, 54 (39.7%) had a positive rRT-PCR test, and 82 (60.3%) had negative rRT-PCR results. Oral manifestations were observed in 40 participants (74.1%) in the rRT-PCR-positive group and 67 participants (81.7%) in the rRT-PCR-negative group. The most common oral manifestations were xerostomia (n = 85; 62.5%) and dysgeusia/ageusia (n = 57; 41.9%). Different rates of gingivitis (n = 12; 22.2% vs. n = 5; 6.1%; p = 0.005) and halitosis (n = 7; 13.0% vs. n = 1; 1.2%; p = 0.007) were observed between the rRT-PCR-positive and -negative groups, respectively. Mouth ulcers, glossitis, tongue coating, and petechiae were reported in both groups without significant differences. Conclusions: A high prevalence of oral manifestations was observed in symptomatic patients with suspected or confirmed COVID-19. Clinical relevance: This study highlights the importance of routine oral examinations by dentists as part of the multidisciplinary care of COVID-19 patients.

Oral lesions in patients with SARS-CoV-2 infection: could the oral cavity be a target organ?

Association of Viral Infections With Oral Cavity Lesions: Role of SARS-CoV-2 Infection

Oral ulcer in SARS-CoV-2 infection: a case report

SARS-CoV-2 infection of the oral cavity and saliva

COVID-19 and oral diseases: Assessing manifestations of a new pathogen in oral infections

Oral Pathology in COVID-19 and SARS-CoV-2 Infection—Molecular Aspects

Oral manifestations of COVID-19 in unvaccinated patients: a cross-sectional study

Single-cell RNA expression profiling shows that ACE2, the putative receptor of COVID-2019, has significant expression in nasal and mouth tissue, and is co-expressed with TMPRSS2 and not co-expressed with SLC6A19 in the tissues

Covid-19 and oral diseases: Crosstalk, synergy or association?

Relationship between oral lesions and severe SARS-CoV-2 infection in intensive care unit patients

Oral manifestations in SARS-CoV-2 infection

Severe acute respiratory syndrome coronavirus 2 pathology and cell tropism in tongue tissues of COVID-19 autopsies

Prevalence and association of oral manifestations with disease severity in patients diagnosed with COVID‑19: A cross‑sectional study

SARS-CoV-2 Infection of Salivary Glands Compromises Oral Antifungal Innate Immunity and Predisposes to Oral Candidiasis

Assessment of oral tissue alterations in patients diagnosed with SARS-CoV-2

Herpesviruses and SARS-CoV-2: Viral Association with Oral Inflammatory Diseases

Is the oral cavity relevant in SARS-CoV-2 pandemic?

Detection of SARS‐CoV‐2 in saliva and characterization of oral symptoms in COVID‐19 patients

Pathogenic Mechanism and Multi-omics Analysis of Oral Manifestations in COVID-19

The oral manifestations and related mechanisms of COVID-19 caused by SARS-CoV-2 infection

Oral manifestations in hospital-admitted COVID-19 patients: a case control study